- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02261987
Resistive Inspiratory Manoeuvre as Airway Clearance Technique in Cystic Fibrosis
Role of Resistive Inspiratory Manoeuvres During Bronchial Drainage Session in Cystic Fibrosis: a Randomized Crossover Trial
Study Overview
Status
Conditions
Detailed Description
It is a multicenter study. 4 different Spain Cystic Fibrosis Foundations are included in the study (Madrid, Valencia, Murcia and Aragón). All patients will perform three different arms of treatment in a crossover randomization. Each arm of treatment will be apply only in one session. The wash-out period will be one week. Before starting the trial, all patients will perform a control session without any intervention, only the outcome measures will be assess.
During the study period the patients' pharmacological treatment remained unchanged
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain
- Cystic Fibrosis Association
-
Murcia, Spain
- Cystic Fibrosis Association
-
Valencia, Spain
- Cystic Fibrosis Association
-
Zaragoza, Spain, 50830
- Universidad San Jorge
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cystic Fibrosis (CF) diagnosed ( established by genotype or sweat sodium>70 mmol/l or sweat chloride of>60 mmol/l)
- Clinically stable at time of study entry (defined as no requirement for antibiotics or change in respiratory medication in the preceding 4 wk);
- Chronic sputum production, at least ≥ 15 ml /24h
- Familiar and trained in the use of autogenic drainage technique (at least 6 months) and resistive inspiratory manoeuvre (at least three previous sessions)
- To be able to provide written, informed consent
Exclusion Criteria:
- Lung function: Forced expiratory volume in 1 second < 30 % pred . ; Forced vital capacity < 40 % pred.
- Active haemoptysis during the previous month
- Supplemental oxygen or non-invasive ventilation (NIV)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Autogenic drainage (AD)
Patients will perform the autogenic drainage technique following the Chevallier and Agostini recommendations.
|
It will be apply in one only session.
The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.
|
Active Comparator: Resistive inspiratory manoeuvre (RIM)
Patients will perform the repetitive inspiratory manoeuvers by breathing through a fixed resistance (Power Breathe device, model KH1) .
Each session will comprise to cycles of 5 inspiratory breaths (60% of maximal inspiratory pressure).
Patients will be stay in both lateral decubitus position (15 min per side).
|
It will be apply in one only session.
The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.
|
Active Comparator: Resistive inspiratory manoeuvre+autogenic drainage
First, patients will perform the resistive inspiratory manoeuvre during 10 minutes (5 min per side).
Right after, patients will perform the autogenic drainage during 20 minutes.The instructions will be similar to described previously.
|
It will be apply in one only session.
The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wet sputum production
Time Frame: 24 hours
|
24h wet sputum production (g) after bronchial drainage session
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wet sputum production
Time Frame: 30 minutes
|
Wet sputum production (g) during bronchial drainage session
|
30 minutes
|
Computerized respiratory sounds
Time Frame: 30 minutes
|
Adventitous respiratory sounds: crackles and wheezes
|
30 minutes
|
Lung function (simply spirometry)
Time Frame: 30 minutes
|
Forced expiratory volume at 1 second, Forced vital capacity, Forced expiratory flow 25-75
|
30 minutes
|
Patients´ perception
Time Frame: 30 minutes
|
Visual analogical scale
|
30 minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pulse-oximetry, heart rate and dyspnea
Time Frame: 30 minutes
|
Safety and tolerability of session
|
30 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Beatriz Herrero, Msc, Universidad San Jorge
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FR_FQ- 013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
The Hospital for Sick ChildrenCanadian Cystic Fibrosis FoundationActive, not recruitingCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in ChildrenCanada
-
AzurRx SASCompletedCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of PancreasTurkey, Hungary
-
Dartmouth-Hitchcock Medical CenterTrustees of Dartmouth CollegeWithdrawnCystic Fibrosis-related Diabetes | Cystic Fibrosis Liver Disease | CF - Cystic FibrosisUnited States
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
University of PortsmouthUniversity Hospital Southampton NHS Foundation Trust; Loughborough University; Queen Alexandra HospitalTerminated
-
University Hospital, BordeauxCompleted
Clinical Trials on Autogenic drainage (AD)
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Cairo UniversityPrincess Nourah Bint Abdulrahman UniversityCompletedPostoperative ComplicationsEgypt
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Carmel Medical CenterRambam Health Care CampusUnknownBronchiectasisIsrael
-
Association Nationale pour les Traitements A Domicile...Recruiting
-
Riphah International UniversityCompletedPneumonia ChildhoodPakistan
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Vrije Universiteit BrusselCompleted
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan